| Raloxifene | Approved Investigational | E2F2 | 1870 |
upregulated | Raloxifene Hydrochloride results in increased expression of E2F2 mRNA | 1p36.12 | |
| Raloxifene | Approved Investigational | EFNA1 | 1942 |
upregulated | Raloxifene Hydrochloride results in increased expression of EFNA1 mRNA | 1q22 | |
| Raloxifene | Approved Investigational | EGR3 | 1960 |
downregulated | Raloxifene Hydrochloride results in decreased expression of EGR3 mRNA | 8p21.3 | |
| Raloxifene | Approved Investigational | EIF2S1 | 1965 |
downregulated | Raloxifene Hydrochloride results in decreased expression of EIF2S1 mRNA | 14q23.3 | |
| Raloxifene | Approved Investigational | EIF5 | 1983 |
downregulated | Raloxifene Hydrochloride results in decreased expression of EIF5 mRNA | 14q32.32 | |
| Raloxifene | Approved Investigational | EIF5A | 1984 |
downregulated | Raloxifene Hydrochloride results in decreased expression of EIF5A mRNA | 17p13.1 | |
| Raloxifene | Approved Investigational | ELF3 | 1999 |
upregulated | Raloxifene Hydrochloride results in increased expression of ELF3 mRNA | 1q32.1 | |
| Raloxifene | Approved Investigational | ELL | 8178 |
upregulated | Raloxifene Hydrochloride results in increased expression of ELL mRNA | 19p13.11 | |
| Raloxifene | Approved Investigational | ELOB | 6923 |
downregulated | Raloxifene Hydrochloride results in decreased expression of ELOB mRNA | 16p13.3 | |
| Raloxifene | Approved Investigational | ELOVL5 | 60481 |
downregulated | Raloxifene Hydrochloride results in decreased expression of ELOVL5 mRNA | 6p12.1 | |
| Raloxifene | Approved Investigational | ENG | 2022 |
upregulated | Raloxifene Hydrochloride results in increased expression of ENG mRNA | 9q34.11 | |
| Raloxifene | Approved Investigational | EPHA1 | 2041 |
upregulated | Raloxifene Hydrochloride results in increased expression of EPHA1 mRNA | 7q34-q35 | |
| Raloxifene | Approved Investigational | EPHA4 | 2043 |
upregulated | Raloxifene Hydrochloride results in increased expression of EPHA4 mRNA | 2q36.1 | |
| Raloxifene | Approved Investigational | ESR1 | 2099 |
upregulated | Raloxifene Hydrochloride results in increased expression of ESR1 mRNA | 6q25.1-q25.2 | |
| Raloxifene | Approved Investigational | F2R | 2149 |
upregulated | Raloxifene Hydrochloride results in increased expression of F2R mRNA | 5q13.3 | |
| Raloxifene | Approved Investigational | FHL2 | 2274 |
downregulated | Raloxifene Hydrochloride results in decreased expression of FHL2 mRNA | 2q12.2 | |
| Raloxifene | Approved Investigational | FLNC | 2318 |
downregulated | Raloxifene Hydrochloride results in decreased expression of FLNC mRNA | 7q32.1 | |
| Raloxifene | Approved Investigational | FOXA2 | 3170 |
upregulated | Raloxifene Hydrochloride results in increased expression of FOXA2 mRNA | 20p11.21 | |
| Raloxifene | Approved Investigational | FOXC1 | 2296 |
downregulated | Raloxifene Hydrochloride results in decreased expression of FOXC1 mRNA | 6p25.3 | |
| Raloxifene | Approved Investigational | FYTTD1 | 84248 |
downregulated | Raloxifene Hydrochloride results in decreased expression of FYTTD1 mRNA | 3q29 | |
| Raloxifene | Approved Investigational | GABPA | 2551 |
upregulated | Raloxifene Hydrochloride results in increased expression of GABPA mRNA | 21q21.3 | |
| Raloxifene | Approved Investigational | GAL | 51083 |
downregulated | Raloxifene Hydrochloride results in decreased expression of GAL mRNA | 11q13.2 | |
| Raloxifene | Approved Investigational | GAS6 | 2621 |
upregulated | Raloxifene Hydrochloride results in increased expression of GAS6 mRNA | 13q34 | |
| Raloxifene | Approved Investigational | GATA2 | 2624 |
upregulated | Raloxifene Hydrochloride results in increased expression of GATA2 mRNA | 3q21.3 | |
| Raloxifene | Approved Investigational | GHR | 2690 |
downregulated | Raloxifene Hydrochloride results in decreased expression of GHR mRNA | 5p13.1-p12 | |